相关实验视频
Updated: May 2, 2026

14:45
Technical Detail for Robot Assisted Pancreaticoduodenectomy
Published on: September 28, 2019
14.6K
在机器人前切除过程中,肥胖和非肥胖患者的客观绩效指标不同
Mishal Gillani1, Manali Rupji2, Terrah J Paul Olson1
1Department of Surgery, Emory University School of Medicine, Atlanta, GA.
Surgery
|September 20, 2024
概括
客观的绩效指标揭示了肥胖患者与非肥胖患者的机器人直肠切除术的差异. 这些指标提供了关于外科医生的运动和复杂手术期间机器人手臂运动的见解.
科学领域:
- 最少侵入性的手术
- 手术机器人手术机器人手术机器人手术机器人
- 在外科手术中的数据分析.
背景情况:
- 肥胖在机器人手术中带来了独特的挑战,可能会增加复杂性.
- 客观绩效指标 (OPI) 提供了关于外科医生技术和机器人手臂运动的可量化的数据.
- 这项研究调查了机器人乳腺切除术中的OPI,比较肥胖和非肥胖患者.
研究的目的:
- 识别和分析肥胖和非肥胖患者队伍在机器人分泌术期间客观绩效指标的差异.
- 根据患者的BMI提供客观的,数据驱动的洞察力,了解基于手术表现的变化.
主要方法:
- 对39次机器人直肠切除术 (13例肥胖,26例非肥胖) 的内镜视频进行分析.
- 1880年手术步骤的注释,重点是脏曲动员,左结肠动员,骨盆剖析和直肠截切.
- 量化OPI,包括臂交换,路径长度,速度和能量激活时间.
主要成果:
- 肥胖患者在脊髓曲动员过程中表现出更多的手臂交换和更长的摄像头路径长度.
- 在肥胖患者中,左结肠调动显示出更长的步骤时间,更多的手臂交换,以及增加的摄像机/手臂指标.
- 骨盆剖析和直肠切割的步骤也显示了OPI的显著差异,例如能量激活时间和摄像头运动,在肥胖个体中.
结论:
- 具体阶段的客观绩效指标在接受机器人直肠切除术的肥胖和非肥胖患者之间存在显著差异.
- 这项研究是第一个将患者属性与外科医生的运动和机器人动力学与机器人结直肠手术中的OPI相关联的研究.
- 客观指标可以增强对不同患者群体的理解,并有可能优化外科训练和技术.
相关概念视频
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440

